03 May 2013, BioSpectrum Bureau , BioSpectrum
Singapore: German company Injex Pharma registered Injex30 needle free injection system with the Chinese State Food and Drug Administration (SFDA). The company's application is supported by its exclusive distributor Hangzhou Hema Medical Equipment.
SFDA is responsible for regulating the market access of medical devices in China. The arduous approval process took more than 1.5 years and has required a detailed documentation.